Litcius/Paper detail

Amelanotic/hypomelanotic lentigo maligna: Dermoscopic and confocal features predicting diagnosis

Maria Antonietta Pizzichetta, Jerry Polesel, Jean Perrot, Pietro Rubegni, Diletta Fiorani, Arianna Rizzo, Ignazio Stanganelli, Serena Magi, Laura Mazzoni, Matelda Medri, Michele M. Dominici, Federica Toffolutti, Francesca Farnetani, Nicola Lippolis, Gioia Pedroni, Silvana Ciardo, Alessandra G. Condorelli, Claudio Conforti, Giovanni Pellacani, Iris Zalaudek, Fabio Puglisi, Élisa Cinotti, the Italian Melanoma Intergroup (IMI), Società Italiana di Dermatologia Chirurgica, Oncologica, Correttiva ed Estetica (SIDCO), and Groupe d'imagerie cutanée non invasive de la Société Française de Dermatologie

2022Journal of the European Academy of Dermatology and Venereology18 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Amelanotic/hypomelanotic lentigo maligna and lentigo maligna melanoma (AHLM/LMM) may be very difficult to diagnose at an early stage. OBJECTIVES: To quantify the predictive value of dermoscopic and reflectance confocal microscopy (RCM) features for AHLM/LMM. METHODS: Dermoscopic and RCM images of histopathologically diagnosed AHLM/LMM, amelanotic/hypomelanotic benign lesions (AHBL), and amelanotic/hypomelanotic basal and squamous cell carcinomas (AHBCC/AHSCC) of the head and neck from consecutive patients were retrospectively collected and blindly evaluated by three observers to assess presence or absence of dermoscopic and RCM criteria. RESULTS: Overall, 224 lesions in 216 patients including LM/LMM (n = 55, 24.6%), AHBL (n = 107, 47.8%) and AHBCC/AHSCC (n = 62, 27.7%) were analysed. Multivariable analysis showed that milky-red areas (OR = 5.46; 95% CI: 1.51-19.75), peripheral light brown structureless areas (OR = 19.10; 4.45-81.96), linear irregular vessels (OR = 5.44; 1.45-20.40), and asymmetric pigmented follicles (OR = 14.45; 2.77-75.44) at dermoscopy, and ≥3 atypical cells in five fields (OR = 10.12; 3.00-34.12) and focal follicular localization of atypical cells at dermo-epidermal junction (DEJ) (OR = 10.48; 1.10-99.81) at RCM were significantly independent diagnostic factors for AHLM/LMM vs. AHBL. In comparison with AHBCC/AHSCC, peripheral light brown structureless area (OR = 7.11; 1.53-32.96), pseudonetwork around hair follicles (OR = 16.69; 2.73-102.07), and annular granular structures (OR = 42.36; 3.51-511.16) at dermoscopy and large dendritic (OR = 6.86; 3.15-38.28) and round pagetoid cells (OR = 26.78; 3.15-227.98) at RCM led to a significantly increased risk of diagnosing AHLM/LMM. CONCLUSIONS: Amelanotic/hypomelanotic lentigo maligna and lentigo maligna melanoma may have the same dermoscopic features of AHM on other body sites, such as milky red areas, peripheral light brown structureless areas and linear irregular vessels. These features, asymmetric pigmented follicles and at RCM ≥ 3 atypical cells in five fields and focal follicular extension of atypical cells at DEJ may help in recognizing AHLM/LMM even when LM conventional features (e.g., obliteration of hair follicles under dermoscopy and large pagetoid cells under RCM) are absent or present only in very small areas of the lesion.

Topics & Concepts

MedicineLentigo maligna melanomaLentigo malignaDermatologyAmelanotic melanomaDermatoscopyPathologyMelanomaCancer researchCutaneous Melanoma Detection and ManagementNonmelanoma Skin Cancer StudiesCutaneous lymphoproliferative disorders research